Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmketamine combined with propofol for anesthesia induction in gastrointestinal surgery
ChiCTR2200060641Phase 4Not yet recruiting
- Sponsor
- Foshan First People's Hospital
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of esketamine and propofol in gastrointestinal stromal tumor (GIST) (2 arms), sponsored by Foshan First People's Hospital. Primary endpoint: Incidence of hemodynamic instability during anesthesia induction. Planned start May 2022; status: not yet recruiting.
02
Drugs
esketaminepropofol
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on ChiCTR2200060641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060641.